Advancing Personalized Medicine

In addition to pharmacogenetic testing, GnomeDX is also a biotechnology development company dedicated to research work. Using our expertise in DNA/RNA and protein detection and analysis, we direct research to better understand chronic diseases, such as Alzheimer’s disease, and to aid the development and testing of drugs that may benefit people with these conditions. We are in the early stages of translational research with a focus on Alzheimer’s disease and chronic heart disease.